Chronic Arterial Responses to Overlapping Paclitaxel-Eluting Stents Insights From Serial Intravascular Ultrasound Analyses in the TAXUS-V and -VI Trials

被引:8
作者
Aoki, Jiro [1 ,2 ]
Mintz, Gary S. [1 ,2 ]
Weissman, Neil J. [3 ]
Mann, J. Tift [4 ]
Cannon, Louis [5 ]
Greenberg, Joel [6 ]
Grube, Eberhard [7 ]
Masud, A. R. Zaki [8 ]
Koglin, Joerg [9 ]
Mandinov, Lazar [9 ]
Stone, Gregg W. [1 ,2 ]
机构
[1] Columbia Univ, Med Ctr, New York, NY 10027 USA
[2] Columbia Univ, Cardiovasc Res Fdn, New York, NY USA
[3] Washington Hosp Ctr, Cardiovasc Res Inst, Washington, DC 20010 USA
[4] Wake Heart Res, Raleigh, NC USA
[5] Cardiac & Vasc Res Ctr No Michigan, Petoskey, MI USA
[6] Florida Heart Inst, Orlando, FL USA
[7] HELIOS Klin, Siegburg, Germany
[8] Buffalo Gen Hosp, Buffalo, NY 14203 USA
[9] Boston Sci Corp, Natick, MA USA
关键词
D O I
10.1016/j.jcin.2007.12.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The purpose of this study was to use intravascular ultrasound (IVUS) to investigate chronic arterial responses at the site of and adjacent to overlapping paclitaxel-eluting TAXUS stents (PES) compared with overlapping bare-metal stents (BMS). Background Increased paclitaxel dose in the PES-overlap region might be associated with arterial toxicity expressed as excessive expansive remodeling, incomplete stent apposition, or aneurysm formation. Methods In the TAXUS-V and -VI trials, 51 patients with overlapping stents (27 PES and 24 BMS) were imaged with serial IVUS immediately after procedure and at 9 months. The IVUS measurements included intimal hyperplasia (IH), peri-stent plaque plus media (P&M), and external elastic membrane (EEM) areas. Vascular responses were assessed at the proximal and distal single stent strut regions and the central overlap region. Results Compared with BMS, all 3 PES stent regions showed: 1) significantly decreased IH (proximal: 0.97 +/- 1.06 mm(2) vs. 3.12 +/- 2.40 mm(2), overlap: 0.74 +/- 0.91 mm(2) vs. 3.23 +/- 1.75 mm(2), distal: 0.88 +/- 0.85 mm(2) vs. 2.69 +/- 1.49 mm(2), all p < 0.05); and 2) increased P&M and EEM areas (Delta P & M; proximal: 0.96 +/- 1.36 mm(2) vs. -0.02 +/- 1.48 mm(2), overlap: 1.56 +/- 1.88 mm(2) vs. 0.29 +/- 1.82 mm(2), distal: 1.03 +/- 1.81 mm(2) vs. 0.11 +/- 0.89 mm(2), all p < 0.05). The IH and changes in EEM and P&M areas were not significantly different in both the BMS and PES groups comparing the single stent strut and overlap regions. Incomplete stent apposition did not occur at the site of overlapping PES in any patient. Conclusions Nine months after stent implantation, neointimal tissue growth was reduced and expansive remodeling was greater with PES compared with BMS-effects that were not exaggerated at the overlap region of PES. (J Am Coll Cardiol Intv 2008;1:161-7) (C) 2008 by the American College of Cardiology Foundation
引用
收藏
页码:161 / 167
页数:7
相关论文
共 34 条
[1]   Twelve-month outcomes with a Paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM registry) [J].
Abizaid, Alexandre ;
Chan, Charles ;
Lim, Yean-Teng ;
Kaul, Upendra ;
Sinha, Nakul ;
Patel, Tejas ;
Tan, Huay-Cheem ;
Lopez-Cuellar, Julio ;
Gaxiola, Efrain ;
Ramesh, Saligram ;
Rodriguez, Alfredo ;
Russell, Mary E. .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (08) :1028-1032
[2]   Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation - Insights from serial intravascular ultrasound analysis in the TAXUS II study [J].
Aoki, J ;
Colombo, A ;
Dudek, D ;
Banning, AP ;
Drzewiecki, J ;
Zmudka, K ;
Schiele, F ;
Russell, ME ;
Koglin, J ;
Serruys, PW .
CIRCULATION, 2005, 112 (25) :3876-3883
[3]   Full metal jacket (stented length ≥64 mm) using drug-eluting stents for de novo coronary artery lesions [J].
Aoki, J ;
Ong, ATL ;
Granillo, GAR ;
McFadden, EP ;
van Mieghem, CAG ;
Valgimigli, M ;
Tsuchida, K ;
Sianos, G ;
Regar, E ;
de Jaegere, PPT ;
van der Giessen, WJ ;
de Feyter, PJ ;
van Domburg, RT ;
Serruys, PW .
AMERICAN HEART JOURNAL, 2005, 150 (05) :994-999
[4]   Strut position, blood flow, and drug deposition - Implications for single and overlapping drug-eluting stents [J].
Balakrishnan, B ;
Tzafriri, AR ;
Seifert, P ;
Groothuis, A ;
Rogers, C ;
Edelman, ER .
CIRCULATION, 2005, 111 (22) :2958-2965
[5]   Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents [J].
Burzotta, Francesco ;
Siviglia, Massimo ;
Altamura, Luca ;
Trani, Carlo ;
Leone, Antonio Maria ;
Romagnoli, Enrico ;
Mazzari, Mario Attilio ;
Mongiardo, Rocco ;
Niccoli, Giampaolo ;
Brancati, Marta ;
Biondi-Zoccai, Giuseppe ;
Rebuzzi, Antonio Giuseppe ;
Schiavoni, Giovanni ;
Crea, Filippo .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (03) :364-368
[6]   Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention [J].
Chu, William W. ;
Kuchulakanti, Pramod K. ;
Torguson, Rebecca ;
Wang, Betty ;
Clavijo, Leonardo C. ;
Suddath, William O. ;
Pichard, Augusto D. ;
Satler, Lowell F. ;
Kent, Kenneth M. ;
Waksman, Ron .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (12) :1563-1566
[7]   Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions [J].
Colombo, A ;
Drzewiecki, J ;
Banning, A ;
Grube, E ;
Hauptmann, K ;
Silber, S ;
Dudek, D ;
Fort, S ;
Schiele, F ;
Zmudka, K ;
Guagliumi, G ;
Russell, ME .
CIRCULATION, 2003, 108 (07) :788-794
[8]   Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial - Support for the use of drug-eluting Stents in contemporary clinical practice [J].
Dawkins, KD ;
Grube, E ;
Guagliumi, G ;
Banning, AP ;
Zmudka, K ;
Colombo, A ;
Thuesen, L ;
Hauptman, K ;
Marco, J ;
Wijns, W ;
Popma, JJ ;
Koglin, J ;
Russell, ME .
CIRCULATION, 2005, 112 (21) :3306-3313
[9]   Pathology of acute and chronic coronary stenting in humans [J].
Farb, A ;
Sangiorgi, G ;
Carter, AJ ;
Walley, VM ;
Edwards, WD ;
Schwartz, RS ;
Virmani, R .
CIRCULATION, 1999, 99 (01) :44-52
[10]   Morphological predictors of restenosis after coronary stenting in humans [J].
Farb, A ;
Weber, DK ;
Kolodgie, FD ;
Burke, AP ;
Virmani, R .
CIRCULATION, 2002, 105 (25) :2974-2980